Members Members Residents Job Board
Join Today Renew Your Membership Make A Donation
2001 Abstract: 566 Ligand Activation Of Alternatively Spliced FGFR-1 Modulates Pancreatic Cancer Cell Malignancy

2001 Digestive Disease Week

# 566 Ligand Activation Of Alternatively Spliced FGFR-1 Modulates Pancreatic Cancer Cell Malignancy
Selwyn M. Vickers, Zhi-Qiang Huang, LeeAnn MacMillan-Crow, John A. Thompson, Birmingham, AL

Pancreatic cancer continues to be a devastating tumor (28,000 new cases/year; 5%-5 year survival). Pancreatic tumors frequently (90%) overexpress fibroblast growth factor ligands (FGF-1, FGF-2) and alternatively spliced high affinity receptors (FGFR-1b). (FGFR-1a previously found in normal pancreatic tissue).

Methods: In vitro: to study the significance of this observation, PANC-1 cells were stably transfected via the pMEXneo vector containing FGFR-1a (PANC-1a) or FGFR-1b (PANC-1b) isoforms. Cells were treated with 150 mM peroxynitrite, 25 and 100 mg/ml of 5-FU. Cells were evaluated for growth inhibition, apoptosis (by fluorescein diacetate/propidium iodide and annexin V staining, caspase 3 activation) and for Bcl-XL/BAX expression (by Western Blot). In vivo: 5x106 cells of each isoform were injected into nude Balb/c mice for xerograft formation (N=8).

Results: In vitro, both PANC-1a and PANC-1b exhibited similar growth rates. Compared to PANC-1b (31%), pro-oxidant (peroxynitrite)-induced apoptosis was significantly (p<0.05) increased in PANC-1a (50%). PANC-1a (70%) demonstrated significantly (p<0.05) increased sensitivity to the cytotoxic effects of 5-FU when compared to PANC-1b (32%). Increased cell death in PANC-1a correlated with increased cell-surface staining for annexin V, activation of caspase-3, and decreased expression of Bcl-XL/BAX. In vivo, PANC-1b readily demonstrated formation of tumor xerograft at 2 weeks; whereas, PANC-1a did not form tumors.

Conclusions: Alternative splicing of FGFR-1 to the b isoform appears to correlate with pancreatic cancer cell growth in vivo and resistance to chemotherapy. Inhibition of FGFR-1 splicing or overexpression of FGFR-1a inhibits pancreatic cancer cell growth in vivo and restores cytotoxic responses to chemotherapy, thereby suggesting the basis of rational interventional strategies for this devastating pathology.

Society for Surgery of the Alimentary Tract

Facebook Twitter YouTube

Email SSAT Email SSAT
500 Cummings Center, Suite 4400, Beverly, MA 01915 500 Cummings Center
Suite 4400
Beverly, MA 01915
+1 978-927-8330 +1 978-927-8330
+1 978-524-0498 +1 978-524-0498
Annual Meeting
Job Board
Make a Pledge
Event Calendar